Hongli Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongli Yu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Hao Wu
College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Key Laboratory of Chinese Medicine Processing, Nanjing University of Chinese Medicine, Nanjing 210023, China; Engineering Center of State Ministry of Education for Standardization of Chinese Medicine Processing, Nanjing 210023, China
8 shared publications Jie Cao
College of Pharmacy, Nanjing University of Chinese Medicine, Qixia District, Xianlin Road No. 138, Nanjing, 210023, China
4 shared publications- Bingbing Liu
Department of Chemistry, Zhejiang University, Hangzhou 310027, China
3 shared publications Min Zeng
College of Pharmacy, Nanjing University of Chinese Medicine, Qixia District, Xianlin Road No. 138, Nanjing, 210023, China
3 shared publications- Bingbing Liu
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China; Jiangsu Key Laboratory of Chinese Medicine Processing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China; Engineering Center of State Ministry of Education for Standardization of Chinese Medicine Processing, Nanjing, Jiangsu, 210023, China; State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
2 shared publications Qinman He
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China
2 shared publications
Latest Publications
- 3 February 2026
- Published by Elsevier in Fitoterapia
- Vol. 190, 107119
New terpenoids from Euphorbia pekinensis with potent and selective anti-hepatocellular carcinoma activity
- 3 February 2026
- Published by Elsevier in Fitoterapia
- Vol. 190, 107119
New terpenoids from Euphorbia pekinensis with potent and selective anti-hepatocellular carcinoma activity
- 19 August 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 353 (Pt B) , 120435
Chebulinic acid shields Villin 1 from covalent attack to mitigate Euphorbia fischeriana enterotoxicity: A basis for safer anti-ascites therapy
- 19 August 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 353 (Pt B) , 120435
Chebulinic acid shields Villin 1 from covalent attack to mitigate Euphorbia fischeriana enterotoxicity: A basis for safer anti-ascites therapy
- 20 June 2025
- Published by Elsevier in Phytomedicine
- Vol. 145, 157017
Cucurbitacin B stimulates PD-1 immunotherapy response in malignant breast cancer by covalent targeting MTCH2
- 20 June 2025
- Published by Elsevier in Phytomedicine
- Vol. 145, 157017
Cucurbitacin B stimulates PD-1 immunotherapy response in malignant breast cancer by covalent targeting MTCH2
- 3 April 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 346, 119716
Corrigendum to “Integrating serum pharmacochemistry, network pharmacology, and metabolomics to elucidate the detoxification and effect-adjusting mechanism of Chebulae Fructus-processing on Mongolian medicine Euphorbia pekinensis”[J. Ethnopharmacol. 345 (2025) 119582]
- 3 April 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 346, 119716
Corrigendum to “Integrating serum pharmacochemistry, network pharmacology, and metabolomics to elucidate the detoxification and effect-adjusting mechanism of Chebulae Fructus-processing on Mongolian medicine Euphorbia pekinensis”[J. Ethnopharmacol. 345 (2025) 119582]
- Open Access
Typhonium giganteum Lectin Exerts A Pro-Inflammatory Effect on RAW 264.7 via ROS and The NF-κB Signaling Pathway
Typhonii rhizoma, a widely used herb in traditional Chinese medicine, has acute irritating toxicity related to Typhonium giganteum lectin (TGL). TGL exhibits acute inflammatory effects, but the underlying molecular mechanisms are largely unknown. This paper is designed to assess the pro-inflammatory response of TGL on RAW 264.7 cells. RAW 264.7 treated with 6.25, 12.5, 25, and 50 µg/mL TGL showed elevated levels of inflammatory factors (TNF-α, IL-1β) and of p-IκB and p-p65, all dose-dependent, indicating that TGL had a substantial inflammatory effect and mobilized the nuclear factor-κB (NF-κB) pathway. All four TGL treatments also induced the up-regulation of reactive oxygen species (ROS) and cytosolic free Ca2+ and down-regulation of mitochondrial membrane potential (MMP). The production of cytokines and p-IκB, p-p65 were reduced by N-acetylcysteine (NAC), an ROS scavenger, which somewhat abrogated ROS production. The results showed the TGL-activated inflammatory signaling pathway NF-κB to be associated with the overproduction of ROS. Moreover, 50 μg/mL treatment with TGL led to cell apoptosis after 1 h and increased necrosis over time. These results provided potential molecular mechanisms for the observed inflammatory response to TGL including up-regulation of ROS and cytosolic free Ca2+, down-regulation of MMP, the mobilization of the NF-κB pathway, and the subsequent overproduction of pro-inflammatory factors resulting in apoptosis. Long-term stimulation with TGL resulted in strong toxic effects related to inflammation that induced necrosis in macrophages.
Open AccessTyphonium giganteum Lectin Exerts A Pro-Inflammatory Effect on RAW 264.7 via ROS and The NF-κB Signaling Pathway
Typhonii rhizoma, a widely used herb in traditional Chinese medicine, has acute irritating toxicity related to Typhonium giganteum lectin (TGL). TGL exhibits acute inflammatory effects, but the underlying molecular mechanisms are largely unknown. This paper is designed to assess the pro-inflammatory response of TGL on RAW 264.7 cells. RAW 264.7 treated with 6.25, 12.5, 25, and 50 µg/mL TGL showed elevated levels of inflammatory factors (TNF-α, IL-1β) and of p-IκB and p-p65, all dose-dependent, indicating that TGL had a substantial inflammatory effect and mobilized the nuclear factor-κB (NF-κB) pathway. All four TGL treatments also induced the up-regulation of reactive oxygen species (ROS) and cytosolic free Ca2+ and down-regulation of mitochondrial membrane potential (MMP). The production of cytokines and p-IκB, p-p65 were reduced by N-acetylcysteine (NAC), an ROS scavenger, which somewhat abrogated ROS production. The results showed the TGL-activated inflammatory signaling pathway NF-κB to be associated with the overproduction of ROS. Moreover, 50 μg/mL treatment with TGL led to cell apoptosis after 1 h and increased necrosis over time. These results provided potential molecular mechanisms for the observed inflammatory response to TGL including up-regulation of ROS and cytosolic free Ca2+, down-regulation of MMP, the mobilization of the NF-κB pathway, and the subsequent overproduction of pro-inflammatory factors resulting in apoptosis. Long-term stimulation with TGL resulted in strong toxic effects related to inflammation that induced necrosis in macrophages.